Liver Fibrosis
📧 Sign up to get email alerts when something new happens for Liver Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Effect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study) [Phase 4]
Phase 4 clinical trial comparing an early time-restricted eating Mediterranean diet to naltrexone/bupropion for liver fibrosis in adults wit…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis [Phase 3]
A Phase 3 clinical trial named LIVERAGE is evaluating Survodutide for metabolic dysfunction-associated steatohepatitis (MASH) with moderate …
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Samsung S-Viscosity vs Canon Dispersion Slope in Steatotic Liver Disease (SAVID-SLD)
This clinical trial entry describes a study comparing S-Viscosity and Canon Dispersion Slope in metabolic dysfunction-associated steatotic l…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease
A recruiting clinical study uses single-cell multiomics and spatiotemporal omics to investigate mechanisms of liver degeneration. Sponsored …
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: The Correlation Between hs CRP TG Triglycerides Glucose Index in NAFLD and Liver Fibrosis
A clinical trial from Assiut University investigates the relationship between hs-CRP, triglycerides, and a glucose index with liver fibrosis…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Screening for MASLD-related Advanced Fibrosis in Type 2 Diabetes [NA]
This clinical trial update notes a NOT_YET_RECRUITING study evaluating screening for MASLD-related advanced liver fibrosis in people with ty…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Volatile Organic Compounds for the Assessment of Liver Disease
A completed clinical trial evaluating volatile organic compounds for the assessment of liver disease.
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Prevalence and Risk Factors of Metabolic-Associated Hepatic Steatosis in Individuals Living With Type 1 Diabetes
This clinical trial update outlines a study to determine how common MASLD is and what risk factors are associated with metabolic-associated …
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Rapid Breath-hold Quantitative Macromolecular Proton Fraction Imaging for Liver Fibrosis
A clinical trial update notes ongoing recruitment for a rapid breath-hold imaging method to quantify macromolecular proton fraction in liver…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Incidence of Liver Disease-Related Outcomes in People With HIV
This is an ongoing clinical trial evaluating liver disease–related outcomes in people living with HIV, focusing on metabolic liver condition…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Copper Supplementation in Cirrhosis [NA]
An ongoing University of Washington clinical trial is evaluating copper supplementation in patients with liver disease, including cirrhosis …
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Exercise for an Aging Liver (EXALIVER) [NA]
EXALIVER is a clinical trial evaluating exercise as an intervention for MASLD and MASH-related liver disease, with the study currently not y…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein [Phase 3]
Phase 3 study to assess the safety and potential efficacy of Fazirsiran for liver disease and fibrosis caused by an abnormal alpha-1 antitry…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: City-Hospital Collaboration for Early Detection of Liver Fibrosis in Primary Care: A Secondary Prevention Project in the Grenoble Health Area
A clinical trial update describing a city-hospital collaboration in Grenoble aimed at early detection of liver fibrosis in primary care as a…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: MR Elastography for Assessing Liver Fibrosis in Chronic Hepatitis B
A clinical trial is recruiting to evaluate MR elastography as a noninvasive method to assess liver fibrosis in patients with chronic hepatit…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Liver Cancer Prevention Randomized Control Trial [NA]
This clinical trial update reports an active-not-recruiting randomized controlled trial aimed at preventing liver cancer. The study lists MD…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in Veterans [Phase 2]
A Phase 2 clinical trial is investigating thyroid hormone as a treatment for nonalcoholic steatohepatitis with liver fibrosis in veterans, a…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: The Phase 1, Open-label, PET Trial Designed to Investigate the Effect of AZD2389 on FAP Occupancy in the Liver in Participants With Advanced Liver Fibrosis. [Phase 1]
Phase 1 open-label PET study to evaluate AZD2389 FAP occupancy in the liver of participants with advanced liver fibrosis. The trial is curre…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Phase IIIc Clinical Study to Evaluate the Long-term Treatment of Hydronidone Capsules for Liver Fibrosis in Patients With Chronic Hepatitis B. [Phase 3]
Phase IIIc clinical trial to evaluate the long-term use of Hydronidone capsules for liver fibrosis in patients with chronic hepatitis B; sta…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Study of Hydroxynidone Capsules in Patients With Hepatic Impairment and Matched Healthy Controls [Phase 1]
Phase 1 study of Hydroxynidone Capsules in patients with liver fibrosis and hepatic impairment; the trial is not yet recruiting and is spons…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Stimulating Fat Tissue Storage With Niacin to Reduce Fat Accumulation in the Liver. [NA]
A clinical trial update from Université de Sherbrooke indicates recruitment for a study testing niacin to stimulate fat storage in adipose t…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Integrated Diagnostics for Early Diagnosis of Liver Disease
This clinical trial entry reports that a study on integrated diagnostics for early detection of liver disease is currently recruiting, evalu…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B Patients [Phase 4]
Phase 4 clinical trial update on empagliflozin for liver fibrosis and cirrhosis in chronic hepatitis B with NAFLD; currently active but not …
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: RTX001 Autologous Engineered Macrophages for Liver Cirrhosis [Phase 1, Phase 2]
RTX001 is an autologous engineered macrophage therapy being investigated in Phase 1/2 trials for end-stage liver disease and liver cirrhosis…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: MASLD in Type 2 Diabetes in Primary Care - a Follow-up Study
This clinical trial update describes a follow-up study examining MASLD in adults with Type 2 diabetes in primary care, with enrollment by in…